Advertisement

Topics

Acucela Inc Company Profile

15:23 EDT 22nd September 2018 | BioPortfolio

Acucela Inc. is a biotech company discovering new drug therapies for eye diseases. Neurodegenerative retinal diseases such as macular degeneration, Stargardt's disease, retinitis pigmentosa and glaucoma, significantly affect quality of life for over 50 million people worldwide, and there is a drastic lack of therapies available. Until now, ophthalmic drug discovery technologies have been very limited.
Acucela uses proprietary OcuScreenTM disease-specific assays and technologies to identify and develop compounds that have safety and efficacy in treating these diseases. These technologies represent a tremendous breakthrough in ophthalmic drug discovery, and Acucela has used them to discover and develop pipeline compounds.

Location

454 North 34th StreetLower Level
Seattle
Washington
98103
United States of America

Contact

Fax: 206.545.3885
Email: info@acucela.com


News Articles [2 Associated News Articles listed on BioPortfolio]

New Acucela Data on the Effect of Emixustat Hydrochloride on Retinal Thickness in Diabetic Retinopathy

Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today new data...

Acucela Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryAcucela Inc Acucela, a subsidiary of Kubota Pharmaceutical Holding is a developer of treatments for degenerative eye diseases and pharmaceutical compound screening system. The company develops ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye di...

Acucela Inc

Acucela Inc. is a biotech company discovering new drug therapies for eye diseases. Neurodegenerative retinal diseases such as macular degeneration, Stargardt's disease, retinitis pigmentosa and glauco...

Acucela

Acucela Inc. (www.acucela.com) is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for...

More Information about "Acucela Inc" on BioPortfolio

We have published hundreds of Acucela Inc news stories on BioPortfolio along with dozens of Acucela Inc Clinical Trials and PubMed Articles about Acucela Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Acucela Inc Companies in our database. You can also find out about relevant Acucela Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record